Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion type Assertion NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_head.
- NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion description "[CAR-modified T cells targeted to the B cell-specific CD19 antigen have demonstrated promising results in multiple early clinical trials, supporting further investigation in patients with B-cell cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_provenance.
- NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion evidence source_evidence_literature NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_provenance.
- NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion SIO_000772 23233573 NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_provenance.
- NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion wasDerivedFrom befree-20150227 NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_provenance.
- NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_assertion wasGeneratedBy ECO_0000203 NP710096.RA_2FGWshuE8g0B9h2K2pUtelRaDM3KCFY78suZLlMZns130_provenance.